> Vielight Neuro Rx Gamma Active Device — Mechanism, Trials &

← All agents | ← Research tracker

Vielight Neuro Rx Gamma Active Device

PubChem entry

Evidence Summary

Evidence Level: Preliminary
Mechanism: Enrollment: Actual, Neurological / Autonomic, Sponsor Type: Industry
Safety: Limited specific safety data in these populations. Review full prescribing information and consult specialist. Many agents used off-label or investigational.
Dosing: See linked studies/trials for reported doses and durations; typical protocols vary widely.
Investigational for listed conditions. 1 associated trial(s) and 0 study reference(s) in current data. Review primary sources and consult specialists before use.

Related Conditions

Long COVID (no page yet)

Clinical Trials

1 trial(s) registered

NCT05857124: A Study Evaluating the Efficacy of the Vielight Neuro RX Gamma in the Treatment of Post COVID-19 Cognitive Impairment PHASE1 COMPLETED

Key Studies / References